A Study of BMS-986528 in Participants With Refractory Rheumatoid Arthritis

Summary

The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and the preliminary evidence of disease-modifying effect of BMS-986528 in participants with refractory, difficult-to-treat rheumatoid arthritis (RA).

Timeline

Start

2026-09-15

Primary completion

2029-10-30

Completion

2030-09-02

Drugs

Indications